Panjon

Panjon Ltd.

BSE: 526345 SECTOR: Pharmaceuticals & Drugs  1040   1   0

14.56
-0.24 (-1.62%)
BSE: 26 May 05:10 PM

Price Summary

Today's High

₹ 15.2

Today's Low

₹ 14.06

52 Week High

₹ 23

52 Week Low

₹ 0

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 22.57 Cr.

Enterprise Value

₹ 21.94 Cr.

No. of Shares

1.55 Cr.

P/E

0

P/B

1.77

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  8.25

CASH

₹ 1.44 Cr.

DEBT

₹ 0.81 Cr.

Promoter Holding

52.03 %

EPS (TTM)

₹  -2.6

Sales Growth

0

ROE

ROCE

Profit Growth

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-42%
3 Year-31.24%
5 Year-9.62%

Profit Growth

1 Year-4856.28%
3 Year-409.54%
5 Year-304.39%

ROE%

1 Year-28.17%
3 Year-9.26%
5 Year-5.24%

ROCE %

1 Year-24.99%
3 Year-7.18%
5 Year-3.39%

Debt/Equity

0.0639

Price to Cash Flow

12.38

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2023 52.03 0
Dec 2022 52.03 0
Sep 2022 52.03 0
Jun 2022 52.03 0
Mar 2022 52.03 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 0.5132213 Cr.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • The company has a high promoter holding of 52.03%.

 Limitations

  • The company has shown a poor profit growth of -409.580423209427% for the Past 3 years.
  • The company has shown a poor revenue growth of -31.239318131847% for the Past 3 years.
  • Company has a poor ROE of -9.26354153085752% over the past 3 years.
  • Company has a poor ROCE of -7.18237666483331% over the past 3 years
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
Net Sales 1.58 1.49 1.93 1.38 1.3
Total Expenditure 5.73 1.45 1.88 1.35 1.41
Operating Profit -4.16 0.04 0.05 0.02 -0.11
Other Income 0.05 0.05 0.05 0.04 0.24
Interest 0.02 0.01 0.01 0.01 0.02
Depreciation 0.03 0.03 0.03 0.03 0.12
Exceptional Items 0 0 0 0 0
Profit Before Tax -4.15 0.04 0.05 0.03 -0.01
Tax 0 0 0 0 0
Profit After Tax -4.15 0.04 0.05 0.03 -0.01
Adjusted EPS (Rs) -2.68 0.03 0.03 0.02 0

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 20.1 25.94 26.43 14.54 8.43
Total Expenditure 19.83 25.67 26.1 14.35 12.48
Operating Profit 0.26 0.27 0.32 0.19 -4.04
Other Income 0.21 0.36 0.29 0.33 0.3
Interest 0.12 0.2 0.15 0.1 0.07
Depreciation 0.11 0.15 0.27 0.23 0.2
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.24 0.28 0.19 0.19 -4.01
Tax 0.12 0.14 0.22 0.1 0.14
Net Profit 0.12 0.14 -0.04 0.09 -4.15
Adjusted EPS (Rs.) 0.08 0.09 -0.02 0.06 -2.68

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 15.5 15.5 15.5 15.5 15.5
Total Reserves 1.13 1.27 1.23 1.31 -2.84
Borrowings 1.4 1.27 1.31 1.07 0.3
Other N/C liabilities -0.94 -0.85 -0.67 -0.6 -0.48
Current liabilities 0.78 0.91 1.18 1.37 1.08
Total Liabilities 17.87 18.1 18.54 18.65 13.57
Assets
Net Block 0.72 0.87 1.12 0.96 0.95
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 1.09 1.09 1.08 1.07 1.07
Loans & Advances 8.09 6.71 4.85 4.57 2.63
Other N/C Assets 0 0 0 0 0
Current Assets 7.97 9.43 11.49 12.05 8.92
Total Assets 17.87 18.1 18.54 18.65 13.57
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 0.24 0.28 0.19 0.19 -4.01
Adjustment 0.11 0.15 0.27 0.23 0.2
Changes in Assets & Liabilities -0.47 0.11 -0.07 -0.06 5.65
Tax Paid -0.05 -0.05 -0.04 -0.03 0
Operating Cash Flow -0.17 0.49 0.35 0.34 1.82
Investing Cash Flow -0.08 -0.31 -0.51 -0.06 -0.19
Financing Cash Flow 0.4 -0.05 -0.07 -0.24 -0.51
Net Cash Flow 0.15 0.13 -0.22 0.04 1.12

Corporate Actions

Investors Details

PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Promoters 52.03 52.03 52.03 52.03 52.03
jay kothari 13.19 13.19 13.18 13.18 13.11
anju jay kothari 12.97 12.97 12.96 12.96 12.97
archit kothari - - 6.45 6.45 6.45
aditya kothari 6.45 6.45 6.45 6.45 6.45
raunaq laboratorie... 6.45 6.45 6.45 6.45 6.45
archit jay kothari 6.45 6.45 - - -
sanitex chemicals ... 3.23 3.23 3.23 - -
varsha bafna 3.23 3.23 3.23 3.23 3.23
sanitex chemicals ... - - - - -
sanitex chemicals ... - - - 3.23 3.23
sajjan bai kothari 0.06 0.06 - 0.06 0.06
sajjan bhai kothari - - 0.06 - -
nagin kothari 0.01 0.01 0.01 0.01 0.01
PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Investors 47.97 47.97 47.97 47.97 47.97
mono herbicides li... - - 11.29 11.29 11.29
monotype india lim... 11.29 11.29 - - -
shardha manish meh... - - 5.65 5.65 -
shradha manish meh... 1.87 1.87 - - -
raju m bora 2.82 2.82 - - -
raju mangilal bora - - 2.82 2.82 -
anil mansukhlal ko... 1.94 1.94 2.82 2.82 -
pavankumar sanwari... - - - - -
mahendra girdharil... 1.30 1.53 - - -
manish gyanchand m... - - 1.31 - -
ashika credit capi... - - - 1.30 -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us
X